These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 16048975

  • 21. Influence of in vitro susceptibility phenotype against thrombin-induced platelet microbicidal protein on treatment and prophylaxis outcomes of experimental Staphylococcus aureus endocarditis.
    Dhawan VK, Yeaman MR, Bayer AS.
    J Infect Dis; 1999 Nov; 180(5):1561-8. PubMed ID: 10515816
    [Abstract] [Full Text] [Related]

  • 22. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
    Bassetti M, Di Biagio A, Del Bono V, Cenderello G, Bassetti D.
    Int J Antimicrob Agents; 2004 Jul; 24(1):83-4. PubMed ID: 15225867
    [Abstract] [Full Text] [Related]

  • 23. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH, Hsu RB.
    Scand J Infect Dis; 2008 Jul; 40(6-7):462-7. PubMed ID: 18584532
    [Abstract] [Full Text] [Related]

  • 24. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
    Woods CW, Cheng AC, Fowler VG, Moorefield M, Frederick J, Sakoulas G, Meka VG, Tenover FC, Zwadyk P, Wilson KH.
    Clin Infect Dis; 2004 Apr 15; 38(8):1188-91. PubMed ID: 15095227
    [Abstract] [Full Text] [Related]

  • 25. The role of vancomycin in the treatment paradigm.
    Stevens DL.
    Clin Infect Dis; 2006 Jan 01; 42 Suppl 1():S51-7. PubMed ID: 16323121
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
    Hamel A, Caillon J, Jacqueline C, Batard E, Potel G.
    Int J Antimicrob Agents; 2008 Feb 01; 31(2):158-60. PubMed ID: 18006281
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G, Moellering RC.
    Clin Infect Dis; 2008 Jun 01; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. New agents for Staphylococcus aureus endocarditis.
    Drees M, Boucher H.
    Curr Opin Infect Dis; 2006 Dec 01; 19(6):544-50. PubMed ID: 17075329
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Management of methicillin-resistant Staphylococcus aureus bacteremia.
    Cosgrove SE, Fowler VG.
    Clin Infect Dis; 2008 Jun 01; 46 Suppl 5():S386-93. PubMed ID: 18462094
    [Abstract] [Full Text] [Related]

  • 34. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
    Sakoulas G, Gold HS, Cohen RA, Venkataraman L, Moellering RC, Eliopoulos GM.
    J Antimicrob Chemother; 2006 Apr 01; 57(4):699-704. PubMed ID: 16464892
    [Abstract] [Full Text] [Related]

  • 35. Retrospective evaluation of therapies for Staphylococcus aureus endocarditis.
    Gentry CA, Rodvold KA, Novak RM, Hershow RC, Naderer OJ.
    Pharmacotherapy; 1997 Apr 01; 17(5):990-7. PubMed ID: 9324187
    [Abstract] [Full Text] [Related]

  • 36. Healthy children with invasive community-acquired methicillin-resistant Staphylococcus aureus infections.
    Stankovic C, Mahajan PV.
    Pediatr Emerg Care; 2006 May 01; 22(5):361-3. PubMed ID: 16714967
    [Abstract] [Full Text] [Related]

  • 37. Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.
    Lodise TP, McKinnon PS, Levine DP, Rybak MJ.
    Antimicrob Agents Chemother; 2007 Oct 01; 51(10):3731-3. PubMed ID: 17664322
    [Abstract] [Full Text] [Related]

  • 38. [Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica].
    Gudiol F, Aguado JM, Pascual A, Pujol M, Almirante B, Miró JM, Cercenado E, Domínguez Mde L, Soriano A, Rodríguez-Baño J, Vallés J, Palomar M, Tornos P, Bouza E, Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica.
    Enferm Infecc Microbiol Clin; 2009 Feb 01; 27(2):105-15. PubMed ID: 19254641
    [Abstract] [Full Text] [Related]

  • 39. Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid.
    Ruiz ME, Guerrero IC, Tuazon CU.
    Clin Infect Dis; 2002 Oct 15; 35(8):1018-20. PubMed ID: 12355391
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Chiang FY, Climo M.
    Antimicrob Agents Chemother; 2003 Sep 15; 47(9):3002-4. PubMed ID: 12937013
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.